Also, Zenith will be presenting at next year's "3rd Annual Epigenetic Inhibitor Discovery: Targeting Histone Methyltransferases, Demethylases and Bromodomains" conference April 19-20, 2016.
Design and Development of Novel BET Bromodomain Inhibitors
Eric Campeau, Ph.D., PMP, Director of Biology, Zenith Epigenetics